The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
A practical guide to large-scale docking
Open accessAbstract
Structure-based docking screens of large compound libraries have become common in early drug and probe discovery. As computer efficiency has improved and compound libraries have grown, the ability to screen hundreds of millions, and even billions, of compounds has become feasible for modest-sized computer clusters. This allows the rapid and cost-effective exploration and categorization of vast chemical space into a subset enriched with potential hits for a given target. To accomplish this goal at speed, approximations are used that result in undersampling of possible configurations and inaccurate predictions of absolute binding energies. Accordingly, it is important to establish controls, as are common in other fields, to enhance the likelihood of success in spite of these challenges. Here we outline best practices and control docking calculations that help evaluate docking parameters for a given target prior to undertaking a large-scale prospective screen, with exemplification in one particular target, the melatonin receptor, where following this procedure led to direct docking hits with activities in the subnanomolar range. Additional controls are suggested to ensure specific activity for experimentally validated hit compounds. These guidelines should be useful regardless of the docking software used. Docking software described in the outlined protocol (DOCK3.7) is made freely available for academic research to explore new hits for a range of targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Within the chemoinformatics space, there are advances in computationally modeling how small molecules and proteins interact via docking.157–159”
From Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882 · cited 6×
“To view this fi le in a protein visualization application, they fi rst must be converted to a pdb fi le. csh $DOCKBASE/proteins/showsphere/doshowsph.csh matching_spheres.sph 1 matching_spheres.pdb Input: matching_spheres.sph Output: matching_spheres.pdb The output fi le, matching_spheres.pdb , can be visualized with the r…”
MethodInfluentialTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
The Cambridge Structural Database
Groom, C. R., Bruno, I. J., Lightfoot, M. P., & Ward, S. C. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616003954 · Cited by 10,297 · cited 2×
“We recently proposed a computational tool that estimates torsion strain energies based on experimentally determined torsional populations in the Cambridge Structural Dataset 129,130 Interaction patterns Speci fi c interactions to key residues are main features of promising candidates.”
MethodExtended-Connectivity Fingerprints
Rogers, D. O. W., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,925
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 7,012 · cited 1×
“Visual examination can catch these strained compounds, but various tools have been developed to systematically analyze hundreds or thousands of compounds making them useful in this setting 127 – 129 .”
MethodDevelopment and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,207
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,340
Comparative Protein Structure Modeling Using Modeller
Eswar, N., Webb, B., Martı́-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Šali, A. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0506s15 · Cited by 4,618
Comparative Protein Structure Modeling Using MODELLER
Webb, B., & Šali, A. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.3 · Cited by 4,404 · cited 1×
“Common programs used for homology modeling include Modeller 52 , Rosetta 53 , ICM 27 and I-Tasser 54 .”
Method
Research works printed but not linked: 2
- Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221–234 (2013). · DOI
- Alon, A. et al. Crystal structures of the σ 2 receptor template large-library docking for selective chemotypes active in vivo. Preprint at bioRxiv https://doi.org/10.1101/2021.04.29.441652 (2021). · DOI
Cited by
Sorted by citations
Items 101–200 of 554
Shafiq, N., Arshad, M., Ali, A., Rida, F., Mohany, M., Arshad, U., Umar, M., & Milošević, M. D. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.04.031 · Cited by 23
Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors
Cieślak, M., Danel, T., Krzysztynska‐Kuleta, O. I., & Kalinowska‐Tłuścik, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-58122-7 · Cited by 23
“This method is often employed to assess docking results 64,65 .”
Computational toolbox for the analysis of protein–glycan interactions
Nieto‐Fabregat, F., Lenza, M. P., Marseglia, A., Carluccio, C. D., Molinaro, A., Silipo, A., & Marchetti, R. (2024) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.20.180 · Cited by 23
Hong, Y., Ha, J., Sim, J., Lim, C. J., Oh, K., Chandrasekaran, R., Kim, B., Choi, J., Ko, J., Shin, W., et al. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00912-2 · Cited by 26
“Despite their high predictive accuracy, MD-based methods require substantial computational resources and time for generating MD trajectories, making them unsuitable for ultra-large-scale virtual screening, particularly when dealing with billions of chemicals [8, 9].”
BackgroundRNA–ligand interaction scoring via data perturbation and augmentation modeling
Ma, H., Gao, L., Jin, Y., Ma, J., Bai, Y., Liu, X., Bao, P., Liu, K., Xu, Z. Z., & Lu, Z. J. (2025) · Nature Computational Science · doi:10.1038/s43588-025-00820-x · Cited by 23
Protein–ligand data at scale to support machine learning
Edwards, A. M., Owen, D. R., Zhang, L., Young, D. W., Willson, T. M., Wellnitz, J., Wang, Y., Walsh, J. J., Vernet, E., Tropsha, A., et al. (2025) · Nature Reviews Chemistry · doi:10.1038/s41570-025-00737-z · Cited by 27
Singh, B. P., Paul, S., Ferreira‐Santos, P., Bhushan, B., Hati, S., Goel, G., & Udenigwe, C. C. (2025) · Food Research International · doi:10.1016/j.foodres.2025.117637 · Cited by 26
Singh, M. B., Vishvakarma, V. K., Lal, A. A., Chandra, R., Jain, P., & Singh, P. (2022) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2022.100790 · Cited by 21
Vlasiou, M. C., Nicolaidou, V., & Papaneophytou, C. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102411 · Cited by 22
“Docking preparation was carried out as previously described [44].”
MethodAI meets physics in computational structure-based drug discovery for GPCRs
Michino, M., Vendôme, J., & Kufareva, I. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00019-0 · Cited by 27
Discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic
Catacutan, D. B., Tran, V., Arnold, A., Alexander, J., Corso, G., Yousefi, Y., Tu, M. M., McLellan, S., Tertigas, D., Corneil, K., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02142-0 · Cited by 27
“This is known as ‘blind apo-structure docking’ 35 , in which traditional methods struggle owing to the vast search space.”
Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2
Yang, J., Xiao, Y., Lidsky, P. V., Wu, C.-T., Bonser, L. R., Peng, S., Garcia-Knight, M., Tassetto, M., Chung, C.-I., Li, X., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-022-01288-5 · Cited by 23
Self-citationBigBind: Learning from Nonstructural Data for Structure-Based Virtual Screening
Brocidiacono, M., Francoeur, P. G., Aggarwal, R., Popov, K. I., Koes, D. R., & Tropsha, A. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01211 · Cited by 24
Kharwar, A., Mishra, A., Singh, V. K., & Tiwari, A. K. (2024) · Chemical Physics Impact · doi:10.1016/j.chphi.2024.100509 · Cited by 21
Deep Learning for Flexible and Site-Specific Protein Docking and DesignPreprint
McPartlon, M., & Xu, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.01.535079 · Cited by 24
Accelerating Ligand Discovery for Insect Odorant Receptors
Comte, A., Lalis, M., Brajon, L., Moracci, R., Montagné, N., Topin, J., Jacquin‐Joly, E., & Fiorucci, S. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.105648 · Cited by 24
“…docking algorithm but rather to apply it on a subset of a large library by prioritizing molecules that occupy the same chemical space as potential hits (by calculating chemical similarity and clustering) 72,73 or by training a machine learning model capable of screening the entire database 74,75 .”
Plasticity of the binding pocket in peptide transporters underpins promiscuous substrate recognition
Kotov, V., Killer, M., Jungnickel, K. E. J., Lei, J., Finocchio, G., Steinke, J., Bartels, K., Strauss, J., Dupeux, F., Humm, A.-S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112831 · Cited by 20
Virtual fragment screening for DNA repair inhibitors in vast chemical space
Luttens, A., Vo, D. D., Scaletti, E. R., Wiita, E., Almlöf, I., Wallner, O. A., Davies, J. R., Košenina, S. P., Meng, L., Long, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56893-9 · Cited by 21
Self-citationSteadman, D., Atkinson, B. N., Zhao, Y., Willis, N. J., Frew, S., Monaghan, A. E., Patel, C., Armstrong, E., Costelloe, K., Magno, L., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01735 · Cited by 19
Power, H. T., Wu, J., Turville, S. G., Aggarwal, A., Valtchev, P., Schindeler, A., & Dehghani, F. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105574 · Cited by 19
“For example, docking against enclosed binding pockets is usually more successful compared to docking against larger, flat and solvent-exposed regions [64].”
Targeting in silico GPCR conformations with ultra-large library screening for hit discovery
Sala, D., Batebi, H., Ledwitch, K. V., Hildebrand, P. W., & Meiler, J. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.12.006 · Cited by 20
Structure-based virtual screening discovers potent and selective adenosine A1 receptor antagonists
Matricon, P. G., Nguyen, A. T. N., Vo, D. D., Baltos, J., Jaiteh, M., Luttens, A., Kampen, S., Christopoulos, A., Kihlberg, J. O., May, L. T., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115419 · Cited by 19
“Several successful structure-based virtual screens have been carried out for such targets, and detailed protocols for docking screens of large commercially available libraries were recently described [24].”
Self-citationOuzounis, S., Panagiotopoulos, V., Bafiti, V., Zoumpoulakis, P. G., Cavouras, D., Kalatzis, I. K., Matsoukas, M., & Κάτσιλα, Θ. (2023) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0075 · Cited by 19
“Our final predictions are based on the morphological differences of each CYP450 cavity, together with the structural and physicochemical differences of the test compounds (ligands) (Bender et al., 2021).”
BackgroundHasan, M. S. A., Bhuia, M. S., Sheikh, S., Bithi, S. A., Saim, M. A., Kamli, H. M., Ansari, S. A., Ahammed, N. T., & Islam, M. T. (2024) · Sleep Medicine · doi:10.1016/j.sleep.2024.12.007 · Cited by 18
Farhadi, B., Beygisangchin, M., Ghamari, N., Jakmunee, J., & Tang, T. (2025) · Biological Cybernetics · doi:10.1007/s00422-025-01026-0 · Cited by 19
“…initial step can involve blind docking, where the entire protein is enclosed within the grid box to allow for an unbiased search of potential binding sites (Bender et al. 2021), and possible binding regions are explored to identify the most favorable BBS for ligand interaction (Lester et al. 2023).”
Kristanti, A. N., Aminah, N. S., Siswanto, I., Manuhara, Y. S. W., Abdjan, M. I., Wardana, A. P., Aung, E. E., & Takaya, Y. (2022) · RSC Advances · doi:10.1039/d2ra03092f · Cited by 18
Chemical Space Virtual Screening against Hard-to-Drug RNA Methyltransferases DNMT2 and NSUN6
Zimmermann, R. A., Fischer, T. R., Schwickert, M., Nidoieva, Z., Schirmeister, T., & Kersten, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076109 · Cited by 18
“As another consequence of the low number of known ligands for the m5C-RNA methyltransferases of interest, also model validation is considered best practice [37], which includes binder vs.”
BackgroundExploring the combinatorial explosion of amine–acid reaction space via graph editing
Zhang, R., Mahjour, B. A., Outlaw, A., McGrath, A., Hopper, T., Kelley, B. P., Walters, W. P., & Cernak, T. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01101-w · Cited by 20
Unbiased MD simulations identify lipid binding sites in lipid transfer proteins
Srinivasan, S., Álvarez, D., Peter, A. T. J., & Vanni, S. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202312055 · Cited by 22
Perspectives on current approaches to virtual screening in drug discovery
Muegge, I., Bentzien, J., & Ge, Y. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2390511 · Cited by 20
“Reports suggest that virtually screening larger chemical spaces leads to more potent hits [37].”
Crivelli-Decker, J. E., Beckwith, Z., Tom, G., Le, L., Khuttan, S., Salomón–Ferrer, R., Beall, J., Gómez‐Bombarelli, R., & Bortolato, A. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c00399 · Cited by 18
Genomic and phenotypic evidence support visual and olfactory shifts in primate evolution
Chi, H., Wan, J., Melin, A. D., DeCasien, A. R., Wang, S., Zhang, Y., Cui, Y., Guo, X., Zhao, L., Williamson, J., et al. (2025) · Nature Ecology & Evolution · doi:10.1038/s41559-025-02651-5 · Cited by 21
“There is a positive correlation between the experiment-activated hits and absolute-affinity scores in the docking screening process 37,38 , thus the ORs with higher absolute affinity to much odorants scores have the notable trend to recognize more odorants, which are considered as BTORs.”
State-of-the-art advances in biotechnology for polyethylene terephthalate bio-depolymerization
Liu, Y., Zhou, J., Li, Y., Yan, X., Xu, A., Zhou, X., Liu, W., Xu, Y., Su, T., Wang, S., et al. (2025) · Green Carbon · doi:10.1016/j.greenca.2025.02.003 · Cited by 18
On the application of artificial intelligence in virtual screening
Thaingtamtanha, T., Ravichandran, R., & Gentile, F. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2508866 · Cited by 18
“Balancing accuracy with computational efficiency remains difficult, hindering the screening of large compound libraries [70,71].”
Computer-Aided Drug Design: An Update
Yu, W., Weber, D. J., & MacKerell, A. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2855-3_7 · Cited by 18
Fukunishi, Y., Higo, J., & Kasahara, K. (2022) · Biophysical Reviews · doi:10.1007/s12551-022-01015-8 · Cited by 18
“…(virtual) drug screenings and the rational drug designs from 1990, and still now a number of reports has been published on the receptor–ligand docking programs and the combinations of them (Pagadala et al. 2017; Salmaso and Moro 2018; Amaro et al. 2018; Bender et al. 2021; Pinzi and Rastelli 2019).”
BackgroundStructure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Kampen, S., Rodriguez, D. J., Jørgensen, M., Kruszyk-Kujawa, M., Huang, X., Collins, M., Boyle, N., Maurel, D., Rudling, A., Lebon, G., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00234 · Cited by 18
“35,36 The enrichment of NAMs was quantified using receiver operating characteristic (ROC) curves, which were used to calculate the adjusted LogAUC values and the ROC-based enrichment factor at 1% (EF 1 , Precent of the ligands identified when 1% of the decoys have been found).”
Self-citationOlfactory Receptors as an Emerging Chemical Sensing Scaffold
Patel, A. J., & Peralta‐Yahya, P. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00486 · Cited by 16
Conserved allosteric inhibition mechanism in SLC1 transporters
Yang, D., Wang, J., Garibsingh, R. A., Hutchinson, K., Shi, Y., Eisenberg, G., Yu, X., Schlessinger, A., & Grewer, C. T. (2023) · eLife · doi:10.7554/elife.83464 · Cited by 16
Kersten, C., Clower, S., & Barthels, F. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01400 · Cited by 15
Leveraging computational tools to combat malaria: assessment and development of new therapeutics
Ncube, N. B., Tukulula, M., & Govender, K. G. (2024) · Journal of Cheminformatics · doi:10.1186/s13321-024-00842-z · Cited by 16
“Structure-based molecular docking has also been found to be capable of prioritizing among ultra-large libraries, and this is crucial in finding unusually potent and selective molecules [38].”
BackgroundA human metabolic map of pharmacological perturbations reveals drug modes of action
Schuhknecht, L., Ortmayr, K., Jänes, J., Bläsi, M., Panoussis, E., Bors, S., Dorčaková, T., Fuhrer, T., Beltrão, P., & Zampieri, M. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02524-5 · Cited by 16
“This is consistent with the view that virtual screening can enrich for likely binders but cannot be used to comprehensively identify all true binders 43 .”
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effects
Tummino, T. A., Iliopoulos‐Tsoutsouvas, C., Braz, J. M., O’Brien, E. S., Stein, R. M., Craik, V., Tran, N. K., Ganapathy, S., Liu, F., Shiimura, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57136-7 · Cited by 25
“Many academic labs or CROs ( Enamine ?) should have accessible polarimeters that may be able to get this data.”
Self-citationDong, J., & Hao, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1534707 · Cited by 15
Synthesis, docking, SAR and ADMET evaluation of novel pyrrolo[3,4-c]pyrazole-4,6-dione derivatives
Zaki, Y. H., Zaki, M., Farag, B., & Gomha, S. M. (2026) · Scientific Reports · doi:10.1038/s41598-025-33678-0 · Cited by 15
“The resulting solids were filtered and recrystallized from ethanol or acetic acid to afford crystalline derivatives 3a–e . and docking was performed with the triangle matcher placement and London dG scoring functions following published procedures 61 .”
Discovery of Covalent Ligands with AlphaFold3
Shamir, Y., Gabizon, R., Rogel, A., Lin, D. Y.-W., Andreotti, A. H., & London, N. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22222 · Cited by 18
Bayrak, A., Mohr, F., Kolb, K., Szpakowska, M., Shevchenko, E., Dicenta, V., Rohlfing, A., Kudolo, M., Pantsar, T., Günther, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01198 · Cited by 13
An open-source molecular builder and free energy preparation workflow
Bieniek, M., Cree, B., Pirie, R., Horton, J. T., Tatum, N. J., & Cole, D. J. (2022) · Communications Chemistry · doi:10.1038/s42004-022-00754-9 · Cited by 16
“High-throughput virtual screening is widely used in hit discovery 1 , but relies on pre-de fi ned libraries of compounds.”
MethodFragment-based screening by protein-detected NMR spectroscopy
Kerber, P. J., Nuñez, R., Jensen, D. R., Zhou, A. L., Peterson, F. C., Hill, R. B., Volkman, B. F., & Smith, B. C. (2023) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.06.018 · Cited by 15
Queirós-Reis, L., Mesquita, J. R., Brancale, A., & Bassetto, M. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00803 · Cited by 15
Serafim, M. S. M., Kronenberger, T., Rocha, R. E. O., Rosa, A. D. R. A., Mello, T. L. G., Poso, A., Ferreira, R. S., Abrahão, J. S., Kroon, E. G., Mota, B. E. F., et al. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01505 · Cited by 14
Accurate Protein-Ligand Complex Structure Prediction using Geometric Deep LearningPreprint
Zhang, J., He, K., Dong, T., & Wu, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1454132/v1 · Cited by 15
Ultra-large library screening with an evolutionary algorithm in Rosetta (REvoLd)
Eisenhuth, P., Ließmann, F., Moretti, R., & Meiler, J. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01758-x · Cited by 19
“However, this introduces potential error sources, as rigid docking might not be able to sample favorable protein – ligand structures 18 .”
Tripathi, A., Suri, K., Sriram, K., & Murugan, N. A. (2025) · RSC Advances · doi:10.1039/d5ra05526a · Cited by 14
Chaudhary, D., Chong, F., Neupane, T., Choi, J., & Jee, J.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413661 · Cited by 14
Islam, M. A., Dudekula, D. B., Rallabandi, V. P. S., Srinivasan, S., Natarajan, S., Chung, H., & Park, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169374 · Cited by 16
“has become the prototype of structure-based screening of various in-house created chemical libraries or virtually available chemical databases [9].”
BackgroundInfluentialDNA-encoded libraries via late-stage functionalization strategies: a review
Sahu, R., Yadav, S., Nath, S., Banerjee, J., & Kapdi, A. R. (2023) · Chemical Communications · doi:10.1039/d3cc01075a · Cited by 14
A Simple Way to Incorporate Target Structural Information in Molecular Generative Models
Zhang, W., Zhang, K., & Huang, J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00293 · Cited by 14
Ghica, A., Drumea, V., Moroșan, A., Mihaiescu, D., Costea, L., Luță, E., Mihai, D., Balaci, D. T., Fița, A., Olaru, O., et al. (2023) · Plants · doi:10.3390/plants12132510 · Cited by 15
“The obtained complexes with pubescenoside A and pterisolic acid B were considered valid after optimal poses were obtained, such as when the expected binding pocket was occupied, conformations were not highly strained, and the number of unsatisfied interactions was acceptable [77].”
BackgroundXDock: A General Docking Method for Modeling Protein–Ligand and Nucleic Acid–Ligand Interactions
Wu, Q., & Huang, S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00855 · Cited by 14
Venkatraman, V., Colligan, T., Lesica, G., Olson, D. R., Gaiser, J., Copeland, C. J., Wheeler, T., & Roy, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.874746 · Cited by 12
“Many of these approaches make use of SBVS and facilitate the use of a variety of docking Bender et al. (2021) programs with signi fi cant emphasis on scaling the calculations.”
MethodYusof, E. N. M., Azam, M., Sirat, S. S., Ravoof, T. B. S. A., Page, A. J., Veerakumarasivam, A., Karunakaran, T., & Razali, M. R. (2022) · Bioinorganic Chemistry and Applications · doi:10.1155/2022/2004052 · Cited by 14
“*e AutoDock parameter file was updated to include van der Waals interactions and other 2-specific parameters retrieved from the AutoDock website [42, 43].”
MethodNo dance, no partner! A tale of receptor flexibility in docking and virtual screening
Basciu, A., Callea, L., Motta, S., Bonvin, A. M. J. J., Bonati, L., & Vargiu, A. V. (2022) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2022.08.006 · Cited by 14
Virtual screening and zebrafish models in tandem, for drug discovery and development
Hernández-Silva, D., Alcaraz‐Pérez, F., Pérez‐Sánchez, H., & Cayuela, M. L. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2147503 · Cited by 12
Andrei, C., Mihai, D. P., Zanfirescu, A., Nițulescu, G. M., & Negreș, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122563 · Cited by 13
“As observed in many drug discovery campaigns, docking scores alone do not often yield remarkably high success rates in discovering true positives [53] or appropriate repurposing candidates.”
BackgroundMethodGandhi, G. R., Sharanya, C. S., Jayanandan, A., Haridas, M., Hillary, V. E., Gandhi, S. R., Sridharan, G., RENGARAJU, S., Vasconcelos, A. B. S., Montalvão, M. M., et al. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2212062 · Cited by 13
“In this setting, higher log AUC values correspond to better discrimination between active and inactive molecules (actives and inactive) and provide a sanity check on the ability of the docking parameters to identify actives (Bender et al., 2021).”
BackgroundDeng, Y., Liu, J., Lu, Y., Fan, X., Yang, Y., Xu, Y., Qin, X., Nian, R., & Liu, W. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04375 · Cited by 13
Smith, L. G., Novak, B., Osato, M., Mobley, D. L., & Bowman, G. R. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00870 · Cited by 15
Technologies for the discovery of G protein–coupled receptor–targeting biologics
Downey, M. L., & Peralta‐Yahya, P. (2024) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2024.103138 · Cited by 13
Wang, H., Li, J., Tu, W., Wang, Z., Zhang, Y., Chang, L., Wu, Y., & Zhang, X. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240301 · Cited by 14
Mai, T. T., Lam, T.-P., Pham, L.-H. D., Nguyen, K.-H., Nguyen, Q., Le, M.-T., & Thai, K. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c03057 · Cited by 14
Ten challenges and opportunities in computational immuno-oncology
Bao, R., Hutson, A. D., Madabhushi, A., Jönsson, V. D., Rosario, S. R., Barnholtz‐Sloan, J. S., Fertig, E. J., Marathe, H. G., Harris, L. N., Altreuter, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009721 · Cited by 14
“27 28 For large-scale phase III randomized trials, the design must consider delays in effects relative to”
Barlow Twins deep neural network for advanced 1D drug–target interaction prediction
Schuh, M. G., Boldini, D., Bohne, A. I., & Sieber, S. A. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-00952-2 · Cited by 13
“1, 2 and 7.”
Ibrahim, S. O., Ayipo, Y. O., Lukman, H. Y., Abubakar, F. A., Na’Allah, A., Katibi-Abdullahi, R. A., Zubair, M. F., & Atolanı, O. (2025) · In Silico Pharmacology · doi:10.1007/s40203-025-00320-w · Cited by 14
“Validating the accuracy of molecular docking protocols is essential to ensure the reliability of predicted binding poses and interaction strengths (Bender et al. 2021 ).”
Structure-based discovery of positive allosteric modulators of the A 1 adenosine receptor
Nguyen, A. T. N., Panel, N., Vo, D. D., Thai, B. S., Chia, L. Y., Lu, C. S., Hellyer, S. D., Langiu, M., Jörg, M., Gregory, K. J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2421687122 · Cited by 13
Self-citationTextGrad: Automatic "Differentiation" via Text
Yuksekgonul, M., Bianchi, F., Boen, J., Liu, S., Huang, Z., Guestrin, C., & Zou, J. (2024) · arXiv · doi:10.48550/arxiv.2406.07496 · Cited by 12
“In particular, docking scores tend to prefer larger molecules with many functional groups that maximize interactions with a binding site [55, 56, 60].”
BackgroundQuantum-machine-assisted drug discovery
Zhou, Y., Chen, J., Cheng, J., Cao, X., Zhang, Y., Karemore, G., Žitnik, M., Chong, F. T., Liu, J., Fu, T., et al. (2026) · npj Drug Discovery. · doi:10.1038/s44386-025-00033-2 · Cited by 27
“CPU/GPU: seconds–minutes/complex; MLdockingoften minutes;AF3 minutes/complex;HPC forlarge cross-docking[76,81, 82,86,201] Not yet feasible for protein-scale interactions; Requiresthousands ofqubits[36] 10 4 -10 5 logical qubits; Days runtime; Full quantum simulation of binding dynamics [33, 202]…”
Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
de Vaca, I. C., Trapkov, B., Shen, L., Vo, D. D., Zhang, X., Yang, Y., Pezeshki, M., Zhang, X., Bällgren, F., Saleh, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66845-y · Cited by 15
Self-citationRinotas, V. E., Liepouri, F., Ouzouni, M., Chalkidi, N., Papaneophytou, C. P., Lampropoulou, M., Vidali, V. P., Kontopidis, G. A., Couladouros, E. A., Eliopoulos, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411290 · Cited by 12
Malatesta, M., Fornasier, E., di Salvo, M. L., Tramonti, A., Zangelmi, E., Peracchi, A., Secchi, A., Polverini, E., Giachin, G., Battistutta, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47466-3 · Cited by 13
“This technique is successfully used for large-scale identi fi cation of potential drugs 12,13 .”
Baliza, L. R. S. P., Freitas, T. R., Gonçalves, E. K. S., Antunes, G. R., Souza, A. J. F., Yoneda, J. D., Duarte, C. L., Andrade, S. N., Sabino, A. D. P., Varotti, F. D. P., et al. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14581 · Cited by 12
El-Ayouty, M. M., Eltahawy, N. A., El-sameaa, A. M. A., Badawy, A. M., Darwish, K. M., Elhady, S. S., Shokr, M. M., & Ahmed, S. A. (2024) · RSC Advances · doi:10.1039/d4ra04496g · Cited by 12
Abchır, O., Khedraoui, M., Yamari, I., Nour, H., Errougui, A., Samadi, A., & Chtita, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308308 · Cited by 12
“In this study, computational methods were employed to forecast the binding affinity and activity of triazole derivatives against the target protein, along with their potential as oral medications [27–29].”
MethodSpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical Libraries
Kalliokoski, T., Turku, A., & Käsnänen, H. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01790 · Cited by 13
Ganai, S. A., Suma Mohan, S., & Padder, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-85868-5 · Cited by 14
Vulpetti, A., Lingel, A., Dalvit, C., Schiering, N., Oberer, L., Henry, C., & Lu, Y. (2022) · ChemMedChem · doi:10.1002/cmdc.202200163 · Cited by 12
Maximizing the integration of virtual and experimental screening in hit discovery
Bajusz, D., & Keserű, G. M. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2085685 · Cited by 11
“Guidelines for large-scale docking based on the DOCK software and the ZINC database were recently published as well [38].”
MethodLibrary size in virtual screening: is it truly a number’s game?
Kontoyianni, M. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2130244 · Cited by 13
Hernandez, C. C., Tarfa, R. A., Miguel I. Limcaoco, J., Liu, R., Mondal, P., Hill, C., Duncan, K. R., Tzounopoulos, T., Stephenson, C. R. J., O'Meara, M. J., et al. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128841 · Cited by 11
Azam, F., & Almahmoud, S. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073302 · Cited by 13
Istıflı, E. S. (2022) · Colorants · doi:10.3390/colorants1020015 · Cited by 11
“success of docking experiments; control molecules are useful in distinguishing real active molecules from real inactive molecules [35].”
BackgroundSpermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
Harms, M., Smith, N., Han, M., Groß, R. M., von Maltitz, P., Stürzel, C. M., Ruiz‐Blanco, Y. B., Almeida‐Hernández, Y., Rodríguez, A., Cathelin, D., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf8251 · Cited by 11
Han, F., Hao, D., He, X., Wang, L., Niu, T., & Wang, J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01350 · Cited by 11
Yao, H., Wang, X., Chi, J., Chen, H., Liu, Y., Jiayi, Y., Yu, J., Ruan, Y., Xiang, X., Pi, J., et al. (2024) · Molecules · doi:10.3390/molecules29050964 · Cited by 11
Nirenjen, S., & Jaishankar, N. (2024) · Current Drug Discovery Technologies · doi:10.2174/0115701638332872240922184903 · Cited by 11
Nirenjen, S., & Narayanan, J. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130735 · Cited by 11
Tripeptides inhibit dual targets AChE and BACE-1: a computational study
Tuan, A., Nguyen, T. H., Quân, P. M., Nguyen, H. T., Long, N. P., Vu, V. V., Phùng, H. T. T., & Ngô, S. T. (2025) · RSC Advances · doi:10.1039/d5ra00709g · Cited by 11
Haghdoost, M., Santos, Y. L. D. L., Brunstetter, M., Ferretti, M. L., Roberts, M., & Bonn‐Miller, M. O. (2024) · Pharmaceuticals · doi:10.3390/ph17050637 · Cited by 11
Vigneron, S. F., Ohno, S., Braz, J. M., Kim, J. Y., Kweon, O. S., Webb, C. M., Billesbølle, C. B., Srinivasan, K., Bhardwaj, K., Irwin, J. J., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c00052 · Cited by 15
Self-citationMoharana, M., Pattanayak, S. K., & Khan, F. (2023) · Molecular Simulation · doi:10.1080/08927022.2023.2202764 · Cited by 10
Metadata
- Authors
- Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., & Shoichet, B. K.
- Affiliations
- University of California, San Francisco (US)
- Uppsala University (SE)
- Frederick National Laboratory for Cancer Research (US)
- Corresponding author
- Shoichet, Brian K.
- ORCID
- Venue
- Nature Protocols
- Published
- 2021-09-24
- Volume
- 16
- Issue
- 10
- Pages
- 4799-4832
- ISSN
- 1750-2799 (ISSN-L)
- 1754-2189
- PMC
- PMC8522653
- OpenAlex
- W3201539868
- Cited by
- 546
- References
- 145
- Citations by year
- 2026: 96 · 2025: 123 · 2024: 140 · 2023: 117 · 2022: 66 · 2021: 4
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-12-09)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Protocols (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH112205)
- National Institute on Drug Abuse (R37DA045657)
- National Institute of General Medical Sciences (T32GM008284, R01GM133836, F32GM136062, T32GM007175, R35GM122481)
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK116195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- structure-based virtual screening, binding energy prediction, melatonin receptors, hit identification, cluster computing, drug discovery
- MeSH terms
- Ligands, Software, Drug Design, Drug Discovery, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review